gabexate has been researched along with Caries, Dental in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, T | 1 |
| Chang, HL | 1 |
| Maeda, S | 1 |
| Uchida, Y | 1 |
| Nakamae, J | 1 |
| Inoki, R | 1 |
1 other study available for gabexate and Caries, Dental
| Article | Year |
|---|---|
Changes of the Met-enkephalin-like peptide content induced by noxious stimuli in the rat incisor pulp.
Topics: Animals; Captopril; Cycloheximide; Dental Caries; Dental Pulp; Dogs; Enkephalin, Methionine; Esters; | 1983 |